tradingkey.logo

BRIEF-Cspc Pharmaceutical Says Syh2059 Tablets Obtains Clinical Trial Approval In U.S.

ReutersFeb 10, 2025 10:12 AM

- CSPC Pharmaceutical 1093.HK:

  • SYH2059 TABLETS OBTAINS CLINICAL TRIAL APPROVAL IN U.S. BY US FDA

Further company coverage: 1093.HK

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI